Government ShutdownSettling the BillI've Always Wondered ...How We Survive

Loading...

0:00
0% played
Power Marketplace’s public service journalism 💙 Give Now
Stories Tagged as

Medicare

How will Medicare decide a fair price for drug negotiations?

by Nancy Marshall-Genzer and Alex Schroeder
Aug 30, 2023
Dan Gorenstein of Tradeoffs explains what factors the federal insurance program will look at and what the next steps are.
The Inflation Reduction Act signed into law last year gives Medicare new muscle to try to negotiate lower drug prices.
FatCamera via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

For seniors who use medical cannabis, the expense can be considerable

by Karen Michel
Jun 16, 2023
More than three dozen states have legalized the medical use of cannabis products. But for some patients, it’s not an affordable option.
While insurance and Medicare will cover the cost for most FDA-approved medications, those who chose medical cannabis typically pay for it out of pocket.
Robyn Beck/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Congress is looking at changes to Medicare. Hospitals aren't thrilled

by Sabri Ben-Achour and Alex Schroeder
May 16, 2023
A little-known payment change could save the federal government $150 billion over the next 10 years.
Right now, there are cases where Medicare pays hospitals more than double what it pays independent doctors for the same care.
sshepard via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

What’s the difference between traditional Medicare and Medicare Advantage?  

by Sabri Ben-Achour , Chris Farrell and Erika Soderstrom
Dec 5, 2022
There’s been a push for original Medicare recipients to switch to Medicare Advantage, but the plans have seen controversy.
Medicare Advantage plans have seen a number of scandals, Marketplace's senior economics contributor explains why.
Apu Gomes/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Medicare rejected a controversial Alzheimer's drug. Participants still ended up paying for it.

by Lily Jamali
Oct 24, 2022
Medicare raised premiums late last year in preparation to cover the drug Aduhelm. Ultimately, Medicare rejected coverage of the drug, with limited exceptions.
Biogen initially priced its Alzheimer’s treatment drug at $56,000 a year. That figure was factored in when Medicare set Part B premiums late last year.
Dominick Reuter/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Over-the-counter hearing aids bring savings and convenience

by Samantha Fields
Oct 17, 2022
Over 40 million Americans with some form of hearing loss could benefit from the ease of buying a hearing aid at their local pharmacy.
Hearing aids are now available over the counter in the United States.
Mario Tama/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Medicare may soon be able to negotiate prescription drug prices

by Matt Levin
Aug 8, 2022
The health policy reform is part of the Democrats' Inflation Reduction Act, which could aid 48 million Medicare recipients.
The Congressional Budget Office estimates that the Inflation Reduction Act will save Medicare $288 billion over the next decade.
Stefani Reynolds/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

For public good, not for profit.

Donate

Democrats reach deal aimed at cutting drug prices for seniors

by Amanda Peacher
Nov 3, 2021
The limited plan would, for the first time, give Medicare the power to negotiate prices directly with pharmaceutical companies.
Medicare Advantage plans are becoming more and more popular, but what exactly do they entail? We got the details from Dr. Fred Hyde, an independent consultant in health care finance and adjunct professor at Georgetown University.
FatCamera via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Who will end up paying the price for Biogen's new Alzheimer's drug?

by Kimberly Adams
Jun 18, 2021
The cost of the newly approved treatment will be about $56,000 a year, much of it paid for by Medicare.
Biogen’s new Alzheimer's treatment drug, Aduhelm, has an annual sticker price of $56,000.
Dominick Reuter/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

What lowering the Medicare eligibility age would mean for health care

by Kimberly Adams
Jun 15, 2021
Among the many issues fighting for space on the political agenda is a Biden campaign promise to lower expand access Medicare.
Medicare Advantage plans have seen a number of scandals, Marketplace's senior economics contributor explains why.
Apu Gomes/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE